Treatment of Bone Defects Resulted after Excision of Enchondroma of the Hand in 15 Patients, Comparing the Techniques of Autologous Bone Graft, Injectable Bone Substitute and Spontaneous Healing
| Autor: | Petru Ciobanu, Andrian Panuta, Iulian Radu, Norin Forna, Stefanita Arcana, Razvan Tudor, Alexandru Covaciu, Victor Niculescu, Vladimir Poroch, Bogdan Puha |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: |
Fluid Flow and Transfer Processes
bone defect Technology autologous bone graft QH301-705.5 Process Chemistry and Technology Physics QC1-999 General Engineering enchondroma injectable bone substitute hydroxyapatite tricalcium phosphate chitosan Engineering (General). Civil engineering (General) Computer Science Applications Chemistry General Materials Science TA1-2040 Biology (General) Instrumentation QD1-999 |
| Zdroj: | Applied Sciences; Volume 12; Issue 3; Pages: 1300 Applied Sciences, Vol 12, Iss 1300, p 1300 (2022) |
| ISSN: | 2076-3417 |
| DOI: | 10.3390/app12031300 |
| Popis: | Background: Enchondroma is the most common benign bone tumor of the hand. Surgical excision of the tumor using curettage is the treatment of choice. The management of the resulting defects is still a controversial topic in the literature. Methods: This retrospective study includes 15 patients diagnosed with solitary enchondroma in the hand bones: eight cases with type A, three cases with type B and four cases with type D according to Takigawa classification. The aim of this study was to compare the course and outcome in the three patient groups treated by curettage associated with natural consolidation of the bone defect, autologous bone graft or injectable synthetic bone substitute in association with plate and screw osteosynthesis. Results: Outcomes were assessed using the DASH score (mean score 2.5) and TAM score (excellent in all patients) with no significant functional differences between the three groups. Defects managed with k-IBS® injectable bone substitute were associated with shorter operating time, simpler surgical technique and less postoperative pain assessed by VAS score. Conclusion: The use of k-IBS® bone substitute is efficient and less technically demanding than autologous bone grafting. The Takigawa classification could be a good indicator for treatment choice. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|